Skip header and navigation

Narrow By

   MORE

2 records – page 1 of 1.

Final report of the impact evaluation and monitoring committee of the 1994 IWK management review

https://libcat.nshealth.ca/en/permalink/provcat53385
[chairperson], Kate Mahon. --Halifax, NS: Izaak Walton Killam-Grace Health Centre for Children, Women & Families , [1996[.
Call Number
WX 150 DC2.1 F46 1996
Location
IWK Health Sciences Library
Call Number
WX 150 DC2.1 F46 1996
Author
Mahon, Kate
Corporate Author
Izaak Walton Killam-Grace Health Centre for Children, Women & Families. Impact Evaluation and Monitoring Committee
Responsibility
[chairperson], Kate Mahon
Place of Publication
Halifax, NS
Publisher
Izaak Walton Killam-Grace Health Centre for Children, Women & Families
Date of Publication
[1996[
Physical Description
60 p.
Subjects (MeSH)
Hospitals, Pediatric
Maternal-Child Health Centers
Hospital Restructuring
Hospital Units - organization & administration
Nova Scotia
Format
Book
Location
IWK Health Sciences Library
Copies
1
Loan Period
2 weeks
Less detail

Special Access Program (SAP) Medications

https://libcat.nshealth.ca/en/permalink/chpams37048
IWK. Pharmacy. Halifax, NS: IWK Health Centre , 2014.
Pamphlet Number
PL-0883
Available Online
View Pamphlet
The Special Access Program (SAP) provides a way for physicians to acquire medications that are not marketed in Canada. These medications are considered for patients with serious or life-threatening conditions when other treatments have been tried and failed or the side effects are intolerable.
Available Online
View Pamphlet
Corporate Author
IWK. Pharmacy
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2014
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Critical Illness - therapy
Medication Systems - organization & administration
Subjects (LCSH)
Critically ill
Hospitals--Drug distribution systems
Abstract
The Special Access Program (SAP) provides a way for physicians to acquire medications that are not marketed in Canada. These medications are considered for patients with serious or life-threatening conditions when other treatments have been tried and failed or the side effects are intolerable.
Responsibility
IWK Pharmacy, Halifax, NS
Pamphlet Number
PL-0883
Zone
All Zones
Less detail